Adherence to guidelines for patients hospitalized with heart failure: A nationwide survey

Israel Medical Association Journal

Volumn 8, Issue 12, 2006, Pages 875-879

  Jotkowitz, Alan B ^a   Porath, Avi ^a   Shotan, Avraham ^b,d,i,j   Mittelman, Moshe ^e,j   Grossman, Ehud ^d,j   Zimlichman, Reuven ^f,j   Lewis, Basil S ^c,i   Caspi, Abraham ^g,k   Gottlieb, Shmuel ^b,h,i   Garty, Moshe ^e,j  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

^f WOLFSON MEDICAL CENTER   (Israel)

^g KAPLAN MEDICAL CENTER   (Israel)

^h BIKUR CHOLIM HOSPITAL   (Israel)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^j TEL AVIV UNIVERSITY   (Israel)

^k HEBREW UNIVERSITY   (Israel)

more..

Author keywords

Angiotensin converting enzyme inhibitors; Beta blockers; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; SPIRONOLACTONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEALTH SURVEY; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFLUENZA; ISRAEL; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PUBLIC HOSPITAL; STREPTOCOCCUS INFECTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEART FAILURE, CONGESTIVE; HOSPITALS, PUBLIC; HUMANS; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT ADMISSION; PATIENT DISCHARGE; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; SPIRONOLACTONE;

EID: 33845908454     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The SOLVD Investigators. Effect of enalapril an mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
2. Pitt B., Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, on behalf of the ELITE II investigators. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure randomized trial - the losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-7.
3. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
4. Pitt B, Zannad F, Remme WJ. et al. The effect of spironolactone on morbidity and mortality in patients with severe congestive heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
5. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22(17):1527-60.
6. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Bethesda, MD: American College of Cardiology Foundation (ACCF), 2001.
7. McGlynn E. A., Asch S. M., Adams J., Keesey J., Hicks I., DeCristofaro A., Kerr E. A. The quality of health care delivered to adults in the Unites States. N Engl J Med 2003;348:2635-45.
8. Komajda M, Follath F, Swedberg K. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003; 24:464-74.
9. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Med Care 1993;31:141-54.
10. Gardner P, Pickering LK, Orenstein WA, Gershon AA, Nichol KL. Guidelines for quality standards for immunization. Clin Infect Dis 2002;35(5):503-11.
11. Cleland JG, Cohen-Solal A, Aguilar JC, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international study. Lancet 2002;360:1631-9.
12. ADHERE - Acute Decompensated Heart Failure National Registry, second quarter 2003 national benchmark report; November 2003: AD001444.
13. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.
14. Welke KF, BootsMiller BJ, McCoy KD. What factors influence provider knowledge of a congestive heart failure guideline in a national health care system. Am J Med Qual 2003;18:122-7.
15. Philips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34.
16. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
17. Thilly N, Briancon S, Julliere Y, Dufay E, Zannad F. Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use. J Eval Clin Pract 2003;9:373-82.
18. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775-9.
19. Ahmed A. American College of Cardiology/American Heart Association Chronic Heart Failure and Management guidelines: relevance to the geriatric practice. J Am Geriatr Soc 2003;51:123-6.
20. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting enzyme benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-45.
21. Lewis EJ, Hunsicker LG, Clarke WR. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
22. Salpeter SR, Ormiston TM, Salpeter EE, Poole PJ, Cates CJ. Cardioselective beta-blockers for, chronic, obstructive pulmonary disease: a meta analysis. Respir Med 2003;97:1094-101.
23. Bo S, Ciccone G, Scaglione L, et al. Warfarin for non-valvar atrial fibrillation: still underused in the 21st century? Heart 2003;89:553-4.
24. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
25. Bratzler DW. Houck PM, Jiang H, et al. Failure to vaccinate medicare inpatients: a missed opportunity. Arch Intern Med 2002;162:2349-56.